whats the difference between semaglutide and tirzepatide vs for Weight Loss Compounded Semaglutide & Tirzepatide 2025:

2022, doi:10.3389/fphar.2022.903160 Martin, Brett R

Retatrutide, a triple agonist, for obesity: A phase 2 trial. New England Journal of Medicine , 389(2), 567-579

Background on GLP-1 and Natural Boosters The growing interest in GLP-1 receptor agonist drugs such as Ozempic, Wegovy, Mounjora, and Trulicity highlights their promising role in weight loss and diabetes management

Constipation and Overflow Diarrhea : Ozempic Can Cause Constipation, and When Hard Stool Gets Backed Up in the Colon, New Liquid Stool May Leak Around the Blockage to Cause Overflow Diarrhea

VRX-0075 (GLP-5) adds amylin for deeper loss but is rat-only